Second Alzheimer's Drug Shows Potential to Delay Disease
WASHINGTON (AP) — Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.
Source: newscenter1.tv
Page 9 - Eric Widera News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eric Widera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eric Widera Today - Breaking & Trending Today
Eli Lilly's Alzheimer's drug donanemab can slow disease: Study
Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.
Source: newswest9.com
Second Alzheimer's drug can slow disease by a few months
Another experimental Alzheimer's drug can modestly slow patients' inevitable worsening — by about four to seven months, researchers reported Monday.
Source: stltoday.com
2nd Alzheimer's drug in pipeline can slow the disease by a few months but with safety risk
New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening. Patients given monthly infusions of Eli Lilly and Co.'s donanemab declined about four to seven months more
Source: smdailyjournal.com
Eli Lilly applies for FDA approval on Alzheimer's drug
Eli Lilly said it applied for full U.S. approval of its Alzheimer's disease drug that's expected to compete with Eisai's Leqembi as the U.S. drugmaker revealed details of a final-stage trial at a conference in Amsterdam.
Source: arkansasonline.com